← Back to catalogue

AIA-PACK 27.29 Sample Diluting Solution

FDA UDI

Class II (US FDA UDI)

by Tosoh Corp.

Identity

Trade Name
AIA-PACK 27.29 Sample Diluting Solution FDA UDI
Generic Name
Cancer antigen 15-3 (CA15-3) IVD, reagent FDA UDI
Model / Reference
N/A FDA UDI

Identifiers

Primary DI / UDI-DI
04560189211094 FDA UDI
FDA Product Code
MOI FDA UDI
GMDN Term
Cancer antigen 15-3 (CA15-3) IVD, reagent FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.6010 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Cancer antigen 15-3 (CA15-3) IVD, reagent

AIA-PACK 27.29 Sample Diluting Solution by Tosoh Corp. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Tosoh Corp.

Sources (1)

  • FDA UDI f5a2c5af-e8ab-41eb-bd67-be46269ec94e 34 fields · synced May 31, 2026